Skip to main content
Log in

Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Severe hemolytic anemia in β-thalassemia major and β-thalassemias/HbE (β-TM) patients requires giving blood transfusions. Chronic blood transfusions lead to iron overload consequence with organs damage and risk of alloantibody-formation. This study evaluates the prevalence of red cell alloimmunization and estimates the risk of alloantibody-formation in chronic transfusion-dependent β-TM patients. This cross sectional study was conducted on 143 β-TM patients receiving regular transfusions. We tried to determine the frequency, types and factors influencing red cell alloimmunization in these transfusion-dependent β-TM patients. Median age of 25 (17.5 %) alloantibody-formation β-TM patients was 19.0 years (inter quartile 15.5–24.0 years). The alloantibodies were Anti-Rh (E) (13.1 %), Anti-Rh (D) (0.7 %). Thirty-four patients (23.8 %) of the sample had splenectomies of which 10 (29.4 %) had alloantibody-formation. The interval from first transfusion to antibody development varied from 1.5 to 14 years. Alloantibody-formation correlated with splenectomy and splenectomy correlated with number of transfusion (p < 0.005). In multiple logistic regression used to estimate the risk of alloantibodies formation with splenectomy; OR and 95 % CI were 2.88 (1.07–7.80), p = 0.037 after adjusting for other co-variates. The rate of red cell alloimmunization was 17.5 % and splenectomy associated with increased alloantibody-formation in these transfusion-dependent β-TM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

β-TM patients:

β-Thalassemia major and β-thalassemias/HbE patients

DHTR:

Delayed haemolytic transfusion reaction

BMI:

Body mass index

WBC:

White blood cell

RBC:

Red blood cell

NRBC:

Nucleated red blood cells

Hb:

Hemoglobin

Hct:

Hematocrit

CGA:

Column gel agglutination

References

  1. Ansari S, Voosogh P, Moshtaghian S. Assessment of frequency of alloimmunization and erythrocyte autoimmunization in transfusion dependent thalassemia patients. Acta Medica Iranica. 2008;46:137–40.

    Google Scholar 

  2. Schonewille H, Haak HL, van ZijI AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39:763–71.

    Article  CAS  PubMed  Google Scholar 

  3. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Arch Pathol Lab Med. 2007;131:708–18.

    PubMed  Google Scholar 

  4. Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusion in a non hematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion. 2006;46:630–5.

    Article  CAS  PubMed  Google Scholar 

  5. Wang LY, Liang DC, Liu HC, Chang FC, Wang CL, Chan YS, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med. 2006;16:200–3.

    Article  PubMed  Google Scholar 

  6. Rudmann SV. Textbook of blood banking and transfusion medicine. 2nd ed. Philadelphia: Elsevier; 2005.

    Google Scholar 

  7. Kossiva L, Paterakis G, Tassiopoulos S, Papadhimitriou SI, Voukouti E, Gligori I, et al. Decreased expression of membrane alpha4 beta1, alpha5 beta1integrins and transferrin receptor on erythroblasts in splenectomized patients with beta-thalassemia intermedia. Parallel assessment of serum soluble transferring receptors levels. Ann Hematol. 2003;82:579–84.

    Article  CAS  PubMed  Google Scholar 

  8. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96:3369–73.

    CAS  PubMed  Google Scholar 

  9. Ameen R, Al-Shemmari S, Al-Humood S, Chowdhary RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion dependent Arab thalassemia patients. Transfusion. 2003;43:1604–10.

    Article  PubMed  Google Scholar 

  10. Sirchia G, Zanella A, Parravicni A, Morelati F, Rebulla P, Masera G. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion. 1985;25:110–2.

    Article  CAS  PubMed  Google Scholar 

  11. Pradhan V, Badakere S, Vasantha K, Korgaonkar S, Panjwani S, Jajoo N. Antibodies to red cells in beta thalassemia major patients receiving multiple transfusions: a short report. Indian J Hematol Blood Transfus. 2001;19:100–1.

    Google Scholar 

  12. Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology. 2010;15:174–7.

    Article  PubMed  Google Scholar 

  13. Sengsuk C, Tangvarasittichai O, Chantanaskulwong P, Pimanprom A, Wantaneeyawong S, Choowet A, et al. Association of iron overload with oxidative stress, hepatic damage and dyslipidemia in transfusion-dependent β-thalassemia/HbE patients. Ind J Clin Biochem. 2013. doi:10.1007/s12291-013-0376-2.

    Google Scholar 

  14. Singer DB. Post splenectomy sepsis. Perspect Pediatr Pathol. 1973;1:285–311.

    CAS  PubMed  Google Scholar 

  15. Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis. 2006;6:226–33.

    Article  PubMed  Google Scholar 

  16. Tripodi A, Cappellini MD, Chantarangkul V, Padovan L, Fasulo MR, Marcon A, et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica. 2009;94:1520–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006;81:670–5.

    Article  PubMed  Google Scholar 

  18. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, et al. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011;153:121–8.

    Article  PubMed  Google Scholar 

  19. Andersen V, Cohn J, Sorensen SF. Immunological studies in children before and after splenectomy. Acta Paediatr Scand. 1976;65:409–15.

    Article  CAS  PubMed  Google Scholar 

  20. Constantoulakis M, Trichopoulods D, Avgoustaki O, Economidou J. Serum immunoglobulin concentrations before and after splenectomy in patients with homozygous β-thalassaemia. J Clin Pathol. 1978;31:546–50.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Schumacher MJ. Serum immunoglobulin and transferrin levels after childhood splenectomy. Arch Dis Child. 1970;45:114–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Wasi C, Wasi P, Thongcharoen P. Serum immunoglobulin levels in thalassaemia and the effects of splenectomy. Lancet. 1971;2:237–9.

    Article  CAS  PubMed  Google Scholar 

  23. Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227–31.

    Article  CAS  PubMed  Google Scholar 

  24. Kapadia A, Desousa M, Markenson A, Miller D, Good R, Gupta A. Lymphoid cell sets and serum immunoglobulins in patients with thalassemia intermedia: relationship to serum iron and splenectomy. Br J Haematol. 1980;45:405–16.

    Article  CAS  PubMed  Google Scholar 

  25. Gascon P, Zdumbos N, Young N. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Int Med. 1984;100:173–7.

    Article  CAS  PubMed  Google Scholar 

  26. Matzner Y, Hershko C, Polliack A, Konlin AM, Izak G. Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol. 1979;42:345–53.

    Article  CAS  PubMed  Google Scholar 

  27. Buffe D, Rimbau C. Immunosuppressive effect of a human hepatic glycoferro-protein 2H globulin. A study on the transformation of normal human lymphocytes. Immunology. 1975;29:175–84.

    PubMed Central  CAS  PubMed  Google Scholar 

  28. Bryan C, Leech SH. Differential inhibition of MLR by iron, and association with HLA phenotype. Immunogenetics. 1981;12:129–40.

    Article  CAS  PubMed  Google Scholar 

  29. DeSousa M, Smithyman A, Tan C. Suggested models of ecotaxopathy in lymphoreticular malignancy. Am J Pathol. 1978;90:497–520.

    CAS  Google Scholar 

Download references

Acknowledgments

We sincerely thank Department of Clinical Pathology, Nan Hospital for financial support. We also sincerely thank all co-workers in the Blood Bank Unit of Nan Hospital, for blood collection and their technical help. We especially thank those who participated and donated blood samples for this study. Finally we sincerely thank Asst. Prof. Dr. Ronald A. Markwardt, Faculty of Public Health, Burapha University, for his critical reading and correcting of the manuscript.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Surapon Tangvarasittichai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jansuwan, S., Tangvarasittichai, O. & Tangvarasittichai, S. Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients. Ind J Clin Biochem 30, 198–203 (2015). https://doi.org/10.1007/s12291-014-0424-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-014-0424-6

Keywords

Navigation